Opioid-Induced Bowel Dysfunction
8 clinical trials · Condition
◉ Watch Opioid-Induced Bowel Dysfunction
| Record | Firm | Date |
|---|---|---|
| The Efficacy of Acupressure in Managing Opioid-induced Constipation (NCT04876508) | Istanbul Aydın University | 2020-08-01 |
| Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) (NCT01298219) | Sucampo Pharma Americas, LLC | 2010-12-01 |
| Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain (NCT01122030) | Shionogi | 2010-05-19 |
| Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone (NCT00620061) | Sucampo Pharma Americas, LLC | 2007-12-01 |
| Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone (NCT00595946) | Sucampo Pharma Americas, LLC | 2007-08-01 |
| Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone (NCT00597428) | Sucampo Pharma Americas, LLC | 2007-08-01 |
Track Opioid-Induced Bowel Dysfunction automatically
Every clearance here is in the API, with alerts when new ones post.